SELECT * FROM `tbl_content` WHERE `c_type` = 'advertise' AND `c_status` = '1' AND `c_is_deleted` = '0' ORDER BY `c_order` desc LIMIT 3 Association of Biotechnology Led Enterprises

News

Bristol-Myers Squibb and Boston Medical Center collaborate to investigate markers of immuno-oncology response and resistance

The comprehensive, multi-dimensional study will place an emphasis on uncovering mechanisms associated with lack of response to Immuno-Oncology (I-O) therapies

Dec 19, 2018

By : By Team ABLE

Kineta enters research collaboration and license agreement with Pfizer

The companies will collaborate to develop and test small molecule agonists that target RIG-I, an innate immunostimulatory pathway that can elicit immunogenic cell death (ICD) in tumors.

Dec 19, 2018

By : By Team ABLE

Lilly and Aduro Biotech partner to develop novel immunotherapies

As part of the agreement, Lilly will gain access to novel molecules from Aduro that are designed to inhibit the cGAS-STING pathway.

Dec 19, 2018

By : By Team ABLE

DBT calls for proposals to establish Biotech-KISAN Hubs

This special Call for Proposals is for establishing Biotech-KISAN Hubs in four agro-climatic zones in the country.

Dec 18, 2018

By : By Team ABLE

Serum Institute’s partner NeuClone develops mAb for breast cancer indication

NeuClone's Perjeta (pertuzumab) biosimilar is partnered with Serum Institute of India (Serum). Under the partnership, NeuClone and Serum are developing ten biosimilars for global markets.

Dec 18, 2018

By : By Team ABLE